Evidence map›Paper›PMID 23499161›Full record

ReviewClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology2013

New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review.

Yasuo Terao, Hideki Fukuda, Yoshikazu Ugawa, Okihide Hikosaka

Open access · greenAbstract readReview
In one paragraph

Review in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Correlation between non-motor symptoms and eye movements in Parkinson's disease patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Yasuo TeraoDepartment of Neurology, University of Tokyo, Japan. yterao-tky@umin.ac.jp
Hideki Fukuda
Yoshikazu Ugawa
Okihide Hikosaka
Fukushima Medical University · JPNational Eye Institute · USSegawa Neurological Clinic for Children · JPThe University of Tokyo · JP

Funding

Neuronal networks for control of eye movementZIAEY000415 · NEI · NATIONAL EYE INSTITUTE · PI HIKOSAKA, OKIHIDE · 2009 to 2025
$35.3M
Neuronal networks for control of eye movementZ01EY000415 · NEI · NATIONAL EYE INSTITUTE · PI HIKOSAKA, OKIHIDE · 2003 to 2008
$2.3M
Intramural NIH HHS Z01 EY000415
6 · The paper itself

Abstract

We reviewed basal ganglia (BG) dysfunction in Parkinson's disease (PD) based on recent findings on saccade performance. Hypometria in all saccade paradigms and impaired initiation of internally triggered saccades such as memory guided saccades (MGS) are reported, whereas visually guided saccades (VGS) are relatively spared, although they are also mildly affected. The ability to inhibit unwanted saccades is also impaired. We propose that three major drives converges on SC to determine the saccade abnormalities. The impairment in VGS may be caused by the excessive inhibition of SC due to the increased BG output, whereas for MGS, decreased activity of the frontal cortex-BG circuit may also be involved. The impaired suppression of unwanted saccades may result from the "leaky" inhibition of SC. When PD patients inspect pictures, they end up exploring a smaller area of them with smaller saccades compared to normal subjects. Levodopa slightly prolongs VGS latency and shortens MGS latency, by altering the balance between the direct and indirect pathways of the BG circuit. In contrast, deep brain stimulation of the subthalamic nucleus improves saccade hypometria in both VGS and MGS, presumably by acting relatively directly on the SC-substantia nigra pars reticulata pathway to remove the excessive SC inhibition.

Indexed as

SaccadesBasal GangliaDeep Brain StimulationHumansMemoryOcular Motility DisordersParkinson DiseasePhotic StimulationSubstantia NigraSubthalamic NucleusSuperior ColliculiBasal gangliaInhibitionParkinson’s diseaseSaccadeSubstantia nigraSuperior colliculus

Identifiers

PMID23499161
PMCPMC11479665
OpenAlexW2048070854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.